What products does Vertex Pharmaceuticals make?
Our Approved Medicines
- KALYDECO® (ivacaftor) Medicine Name.
- ORKAMBI® (lumacaftor/ivacaftor)
- SYMDEKO® (tezacaftor/ivacaftor and ivacaftor)
- SYMKEVI® (tezacaftor/ivacaftor) + KALYDECO® (ivacaftor)
- TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
- KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) + KALYDECO® (ivacaftor)
Is Vertex Big Pharma?
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry….Vertex Pharmaceuticals.
Type | Public company |
---|---|
Revenue | US$3.04 billion (2018) |
Number of employees | 3,900 |
Website | vrtx.com |
Is Vertex Pharmaceuticals a good company?
Vertex Pharmaceuticals has an overall rating of 4.1 out of 5, based on over 812 reviews left anonymously by employees. 82% of employees would recommend working at Vertex Pharmaceuticals to a friend and 84% have a positive outlook for the business. This rating has improved by 10% over the last 12 months.
What does Vertex Pharma do?
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease.
What type of a company is Vertex Pharmaceuticals?
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.
Should you invest in Vertex?
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Vertex Pharmaceutic is ‘Strong Buy’.
What type of company is vertex?
global biotechnology company
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.
Is Vertex a Fortune 500 company?
Vertex Pharmaceuticals | 2022 Fortune 500 | Fortune.
How many employees does Vertex Pharmaceuticals have?
3,900Vertex Pharmaceuticals / Number of employees
What type of company is Vertex?
What sector is Vertex Pharmaceuticals?
healthcare sector
Vertex Pharmaceuticals serves healthcare sector worldwide.
Who is the CEO of Vertex Pharmaceuticals?
Reshma Kewalramani (Apr 1, 2020–)Vertex Pharmaceuticals / CEO
Will VRTX go up?
Is VRTX stock going to rise? Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Is VRTX a buy Zacks?
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank….Momentum Scorecard. More Info.
Zacks Rank | Definition | Annualized Return |
---|---|---|
4 | Sell | 5.35% |
5 | Strong Sell | 2.45% |
S&P | 500 | 10.91% |
How many employees does vertex have?
What sector is Vertex Pharmaceuticals in?
How many employees does Vertex have?
How much does the CEO of Vertex make?
Vertex CEO Reshma Kewalramani took the helm last April as one of a few women leading a drugmaker. Now, her pay package has gone public—and it’s smaller than the compensation collected by her peers. She nabbed $9.11 million for 2020, about half of what her predecessor, Jeffrey Leiden, made his final year in the CEO job.
Should I sell VRTX?
Out of 15 analysts, 6 (40%) are recommending VRTX as a Strong Buy, 2 (13.33%) are recommending VRTX as a Buy, 6 (40%) are recommending VRTX as a Hold, 1 (6.67%) are recommending VRTX as a Sell, and 0 (0%) are recommending VRTX as a Strong Sell. What is VRTX’s earnings growth forecast for 2022-2024?